Mustang Bio Inc (MBIO)’s stock is trading at $0.23 at the moment marking a fall of -10.83% from the last session close. As of this writing, shares are priced at -85.05% less than their 52-week high of $1.53, and 78.61% over their 52-week low of $0.13. Based on the past 30-day period, the stock price is -47.71% below the high and +49.12% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, MBIO’s SMA-200 is $0.3140.
How does Mustang Bio Inc (MBIO) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a Strong Sell. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.
Mustang Bio Inc (MBIO): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 1 different analysts, who are expecting earnings to fall in between the range of -0.11 and -0.11 with an average Earnings Estimate of -0.11 which is in contrast with the last year earnings estimate of -0.71 and also replicates 84.51% growth rate year over year.
Mustang Bio Inc (NASDAQ: MBIO) Ownership Details
I will give a breakdown of the key shareholders in Mustang Bio Inc (MBIO). Recent figures show that the company’s insiders hold 15.68% of shares. A total of 32 institutional investors hold shares in the company, making 5.72% of its stock and 6.79% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is Geode Capital Management, LLC holding total of 245.49 shares that make 0.52% of the company’s total number of shares and are currently priced at 55087.0.
The securities firm Citadel Advisors Llc holds 112.77 shares of MBIO, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.24%, and the holding percentage of shares is valued at 25306.0.
An overview of Mustang Bio Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Mustang Bio Inc (MBIO) traded 21,361,779 shares per day, with a moving average of $0.1943 and price change of +0.0305. With the moving average of $0.2114 and a price change of -0.0643, about 9,149,544 shares changed hands on average over the past 50 days. Finally, MBIO’s 100-day average volume is 5,564,347 shares, alongside a moving average of $0.2379 and a price change of -0.1565.
